Drug Availability Update
Further to DrugAlert Volume 588, HPS Pharmacies advise that Pfizer Australia is experiencing a supply interruption for aminophylline ampoules as follows:
DBL™ Aminophylline Injection
Supplies are expected to return to normal by end-July 2020. To ensure continuity of supply, Pfizer Australia has arranged an alternative aminophylline product to be available for substitution under Section 19A of the Therapeutic Goods Act 1989.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer Australia on 1800 629 921 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates